Puche Luisa 4
4 · Enochian Biosciences Inc · Filed Jun 21, 2019
Insider Transaction Report
Form 4
Puche Luisa
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2019-06-06$6.15/sh+15,000$92,250→ 15,000 totalExercise: $6.15Exp: 2029-01-07→ Common Stock (15,000 underlying) - Award
Option to Purchase Common Stock
2019-06-06$6.15/sh+60,000$369,000→ 60,000 totalExercise: $6.15Exp: 2029-01-07→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]On June 6, 2019, Ms. Puche was granted options to purchase sixty thousand (60,000) shares of the Company's common stock vesting in equal amounts annually over three years from January 7, 2019, the date of her appointment as Chief Financial Officer of Enochian Biosciences, Inc., pursuant to the Company's 2014 Equity Incentive Plan.
- [F2]On June 6, 2019, Ms. Puche was granted fifteen thousand (15,000) restricted stock units, vesting in equal amounts annually over three years from January 7, 2019, the date of her appointment as Chief Financial Officer of Enochian Biosciences, Inc.